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Abstract
A reversible, reaction-based sensor for biological mobile zinc was designed, prepared, and
characterized. The sensing mechanism of this probe is based on the zinc-induced, ring-opening
reaction of spirobenzopyran to give a cyanine fluorophore that emits in the deep-red region of the
electromagnetic spectrum. This probe is not activated by protons and operates efficiently in
aqueous solution at pH 7 and high ionic strength. The mechanism of this reaction was studied by
using a combination of kinetics experiments and DFT calculations. The biocompatibility of the
probe was demonstrated in live HeLa cells.
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Introduction
Zinc is an essential trace element in biology.[1, 2] Although most biological zinc occurs as a
structural component of proteins,[3] there are pools of readily chelatable, or mobile, zinc in
specific organs such as the brain,[4, 5] pancreas,[6] and prostate.[7] In the hippocampus, high
concentrations of mobile zinc stored in vesicles at glutamatergic synapses[8] have been
conclusively associated with long-term potentiation.[9] Mobile zinc also plays an important
role in sensory perception.[10–13] In the pancreas, insulin crystallization depends on the
expression of the zinc transporter ZnT8,[14] and zinc can be used as a surrogate for imaging
insulin secretion.[15] Mobile zinc accumulates in epithelial cells in the prostate,[16] and a
firm link has been established between intracellular zinc levels and prostate cancer.[17]
The development of luminescent sensors for mobile zinc has provided important tools for
investigating its many biological roles.[18, 19] Although these probes utilize various sensing
mechanisms, most rely on the modulation of photoinduced electron transfer (PET) for their
fluorescence turn-on response.[20] PET-based probes are often sensitive to pH,
however,[21, 22] and do not operate efficiently at long wavelengths, >700 nm. These
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limitations restrict the information that can be obtained using fluorescent sensors, especially
because long wavelength emitting probes are preferred for studies in vivo.[23, 24]
Probes that emit a luminescent signal following a chemical reaction have been developed
recently.[25, 26] A limitation of such “reaction-based” probes, however, is their
irreversibility, which precludes their application to real-time monitoring of concentration
changes.
In the present study, we sought to prepare a reaction-based sensor for Zn2+ that is reversible,
pH-insensitive, and emits at long wavelengths. We recognized that switching reactions offer
an ideal platform for sensor development because of their reversibility. The equilibrium
between spirobenzopyrans and their cyanine forms provides an excellent example of a
thermodynamically reversible switching reaction that has been exploited extensively in
materials science.[27] This reaction is generally driven by light, but examples of chelation-
induced switching have also been reported.[28, 29] Here, we report the design, synthesis, and
mechanistic study of SpiroZin1, a sensor that comprises dipicolylamine as the zinc-binding
unit, appended to a spirobenzopyran scaffold as well as its application in live cell imaging.
Results and Discussion
Synthesis and Characterization
SpiroZin1 was synthesized in a one-pot procedure starting from commercially available
dipicolylamine (DPA) and the readily accessible building blocks 1 and 2 (Scheme 1A). The
reaction involves nucleophilic attack of DPA on the benzylic chlorine of 2, followed by
Knoevenagel condensation of the intermediate aldehyde with 1. SpiroZin1 was isolated as a
pale pink, waxy solid that forms nearly colorless solutions in common organic solvents such
as CH3OH, CH3CN, CH2Cl2, and DMSO. 1H NMR spectroscopic measurements in CD3OD
(Figures SI-1 and SI-2) revealed two diastereotopic singlets for the two methyl groups on
the dihydroindole ring and two diastereotopic doublets for the methylene that connects the
DPA arm (Scheme 1B) with the spirobenzopyran core (Figure SI-3). In addition, the two
vinylic hydrogen atoms on the benzopyran ring have a coupling constant 3JH–H = 7.5 Hz,
consistent with cis stereochemistry. These observations demonstrate that SpiroZin1 exists
predominantly as the spirobenzopyran isomer (Scheme 1B). Addition of 1 equiv. of ZnCl2
turned the color of SpiroZin1 to a deep red. 1H NMR spectra of this solution revealed only
one singlet for the methyl groups on the indolenine ring and a singlet for the methylene
group that connects DPA with the rest of the molecule (Scheme 1B). The coupling constant
of the vinylic hydrogens also changed to 3JH–H = 16.5 Hz, consistent with trans geometry of
the alkene. These NMR signals prove that, in the presence of Zn2+, the spirobenzopyran ring
is opened to produce the cyanine form.
Sensing Properties
The photophysical properties of SpiroZin1 were investigated in aqueous buffer (50 mM
PIPES, 100 mM KCl, pH 7). Under these conditions, SpiroZin1 absorbs only weakly in the
region between 400–700 nm (Figure 1). No fluorescence could be detected for this solution
upon excitation at 500 nm. Following addition of 10 equiv. of ZnCl2, however, a strong
band appeared at λmax = 508 nm (1.40(3) × 104 M−1 cm−1). Excitation at 508 nm produced
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fluorescence in the deep-red region at λmax = 650 nm (ϕ = 0.0042(7), Figure 1). Despite the
low quantum yield of the probe in the zinc-bound form, SpiroZin1 efficiently detects mobile
Zn2+ because of the very low background in both the absorption and emission spectra of the
apo form.
Titration of SpiroZin1 with ZnCl2 revealed formation of a 1:1 complex (Figure SI-5). We
propose a binding mode involving the three nitrogen atoms of the DPA arm and the oxygen
atom on the cresol ring, which triggers the spirobenzopyran ring-opening reaction. This
binding mode maintains the [N3O] coordination sphere of previously reported sensors, such
as those in the ZP family,[30, 31] ZPP1,[32] and the recently reported ZBR probes.[33]
SpiroZin1 chelates Zn2+ tightly with an apparent dissociation constant (Kd) of 21(1) pM
(Figure SI-6).
The selectivity of SpiroZin1 for biologically relevant metal cations was investigated.
Alkaline and alkali-earth metals produce no change in the fluorescence or absorbance
spectra of SpiroZin1 (Figure SI-7). Paramagnetic transition metals increased the absorbance
but not the fluorescence, suggesting that they cause ring opening, but their partially filled d-
orbitals quench the fluorescence of the resulting cyanine. Cadmium increases both
fluorescence and the absorbance, but to a lesser extent than zinc (Figure SI-7).
An advantage of SpiroZin1 is its ability to operate at low pH. The fluorescence of SpiroZin1
turns on at pH 4, 5, and 6 (Figure 2), but this increase is very small compared with the turn-
on induced by Zn2+ at these pH values (Figure 2).
Mechanistic Studies
SpiroZin1 is unique among reaction-based probes because of its reversibility. We
investigated the reaction kinetics of both the turn-on event induced by Zn2+ and the turn-off
process caused by its removal following addition of the chelating agent
ethylenediaminetetraacetic acid (EDTA). The turn-on process is very rapid and was
monitored by stopped-flow spectrophotometry. Similar results were obtained by stopped-
flow fluorescence spectroscopy (Figure SI-8). This study revealed that turn-on occurs in two
steps, each of which could be modeled by a single exponential function (Figure 3). The first
process is fast with t1/2 = 5.89(9) ms and the second step is slower, with t1/2 = 1.17(2) s.
Overall, the turn-on event occurs within seconds under physiological conditions. The turn-
off process, on the other hand, can be modeled by a single exponential decay as determined
by fluorescence spectroscopy (Figure 3) and is slow, with t1/2 = 8.55(1) min.
To understand the mechanism of the sensing reaction of SpiroZin1, we carried out an
intrinsic reaction coordinate analysis using density functional theory (DFT) at the BP86/
TZVP/LANL2DZ level of theory. We decided to model only the electronic ground state of
each reaction intermediate because the experimental observations demonstrate chelation of
Zn2+ to be the main driving force of the reaction. We note that the presence of light might
influence the reaction mechanism and that our calculations are meant to provide only a
qualitative representation.
Rivera-Fuentes and Lippard Page 3
ChemMedChem. Author manuscript; available in PMC 2014 June 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
The reaction was modeled starting from a zinc complex of SpiroZin1 in the spirobenzopyran
form (Figure 4, structure A). The first step in the reaction is ring opening (B) to afford a cis
cyanine as an intermediate (C). The calculated activation energy for this process is only 2.8
kcal mol−1, which agrees qualitatively with the fast step observed by stopped-flow kinetics.
The second step of the reaction is isomerization of the alkene (D) to give the final trans
cyanine (E). The higher calculated activation energy of this process is also consistent with
the slower kinetics measured. In the opposite direction, the slow cis/trans isomerization
occurs first and is the rate-determining step, which agrees with the single exponential decay
of fluorescence observed experimentally.
Live Cell Imaging
The ability of SpiroZin1 to report on the arrival of mobile zinc in live cells was assessed by
using human cervical cancer cells (HeLa). HeLa cells were incubated at 37 °C with 5 μM
SpiroZin1 for 30 min before imaging. Considerable intracellular red fluorescence was
detected under these conditions (Figure 5, panel B). The reason for this high background
fluorescence might be the relatively high concentration of endogenous mobile Zn2+ in HeLa
cells (~100 pM)[34] and the high Zn2+ affinity of SpiroZin1 (21(1) pM). The intracellular
fluorescence, however, increased further upon incubation of the cells with 20 μM ZnCl2 and
50 μM concentrations of the Zn2+ ionophore 2-mercaptopyridine oxide (pyrithione) (Figure
5, panel C). Quantification of the fluorescence intensity revealed that addition of the
exogenous zinc elicited a 2.5(5)-fold turn-on. Addition of the cell-permeable chelator N,N,N
′,N′-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN) reduced the fluorescence confirming
that the fluorescence turn-on is induced by zinc (Figure 5, panel D).
Summary and Conclusions
We describe the design, synthesis, and characterization of a red-emitting sensor for mobile
zinc. This sensor, SpiroZin1, is based on the ring-opening reaction of spirobenzopyran to
form a fluorescent cyanine. This reaction is induced by Zn2+, can be reversed upon
treatment with a chelator, and operates even at low pH. Studies using stopped-flow kinetics,
fluorescence spectroscopy, and DFT calculations provided mechanistic details of the sensing
mechanism. The biocompatibility of this sensor was assessed in cultured HeLa cells.
The modular synthesis of SpiroZin1 allows for modification of the metal-binding site, which
will be useful for tuning its affinity and selectivity. We envision that this design principle
will inform the construction of probes that emit at even longer wavelengths.
Experimental Section
General Materials and Methods
All reagents were purchased from commercial sources and used as received. Compounds
1[35] and 2[36] were prepared according to published methods. Solvents were purified and
degassed by standard procedures. NMR spectra were acquired on a Varian Inova-300
instrument. 1H NMR chemical shifts are reported in ppm relative to SiMe4 (δ = 0) and were
referenced internally with respect to residual protons in the solvent (δ = 3.31 for (CH3OH).
Coupling constants are reported in Hz. 13C NMR chemical shifts are reported in ppm
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relative to SiMe4 (δ = 0) and were referenced internally with respect to solvent signal (δ =
49.00 for (CD3OD). Low-resolution mass spectra (LRMS) were acquired on an Agilent
1100 Series LC/MSD Trap spectrometer (LCMS), using electrospray ionization (ESI). High-
resolution mass spectrometry (HR-ESI-MS) was conducted by staff at the MIT Department
of Chemistry Instrumentation Facility on a Bruker Daltonics APEXIV 4.7 T FT-ICR-MS
instrument. The IUPAC name of SpiroZin1 is provided and was determined using CS
ChemBioDrawUltra 12.0.
Synthesis of 1-(pyridin-2-yl)-N-(pyridin-2-ylmethyl)-N-((1′,3′,3′,6-
tetramethylspiro [chromene-2,2′-indolin]-8-yl)methyl)methanamine
(SpiroZin1)—Compound 2 (150 mg, 0.728 mmol) and K2CO3 (302 mg, 2.18 mmol) were
added to a Schlenk flask that was evacuated and refilled with nitrogen three times. A
solution of DPA (290 mg, 1.46 mmol) in ethanol (7 mL) was added via syringe. The mixture
was stirred at 25 °C for 1 h. Compound 1 (219 mg, 0.728 mmol) was added in one portion
and the mixture was heated to reflux for 1 h. The suspension was filtered and the filtrate was
evaporated. The residue was purified by flash column chromatography (Brockmann 1, basic
Al2O3; CH2Cl2) to give a pale pink solid (148 mg, 40%). M.p.: 50–51 °C; Rf = 0.24
(Brockmann 1, basic Al2O3; CH2Cl2); 1H NMR (300 MHz, CD3OD): 1.13 (s, 3H), 1.24 (s,
3H), 2.20 (s, 3H), 2.66 (s, 3H), 3.33 (d, J = 18 Hz, 1H), 3.52 (d, J = 18 Hz, 1H), 3.59 (s,
4H), 5.71 (d, J = 7.5 Hz, 1H), 6.47 (d, J = 7.5 Hz, 1H), 6.75–6.87 (m, 2H), 6.81 (s, 1H), 6.99
(s, 1H), 7.00–7.10 (m, 2H), 7.18–7.23 (m, 2H), 7.45 (d, J = 6 Hz, 2H), 7.67–7.70 (m, 2H),
8.34 (d, J = 6 Hz, 2H); 13C NMR (75 MHz; CD3OD): 19.43, 19.56, 25.23, 28.06,51.30,
52.03, 59.72, 104.43, 106.60, 118.99, 119.01, 121.24, 122.46, 123.31, 123.39, 126.47,
127.40, 128.93, 129.68, 131.24, 136.88, 137.46, 148.00, 148.24, 150.38, 159.28; HR-ESI-
MS: Calcd for [C33H35N4O]+: 503.2811, found: 503.2818.
Spectroscopic Methods
All aqueous solutions were prepared using de-ionized water with resistivity 18.2 mΩ cm−1,
obtained using a Milli-Q water purification system. Solvents were procured from Aldrich
and used as received. Piperazine-N,N′-bis(2-ethanesulfonic acid) (PIPES) and 99.999% KCl
were purchased from Calbiochem. Stock solutions of SpiroZin1 in DMSO were prepared at
a concentration of 5 mM and stored at −20 °C in 1 mL aliquots and thawed immediately
before each experiment. All spectroscopic measurements were conducted in aqueous buffer
containing 50 mM PIPES (pH 7) and 100 mM KCl. UV-visible spectra were acquired on a
Cary 50 spectrometer using quartz cuvettes from Starna (1 cm path length). Fluorescence
spectra were acquired on a Photon Technology International fluorimeter. All measurements
were conducted at 25 °C maintained by circulating water baths. Extinction coefficients were
determined in the 1 to 5 μM range in aqueous buffer. Fluorescence quantum yields were
determined by using 1 to 5 μM sensor aqueous buffer solutions, exciting at 508 nm.
Fluorescence emission spectra were integrated from 550 to 800 nm. The quantum yield
calculation was standardized to resorufin, with a reported quantum yield of 0.74 at pH 9.5,
λex = 572 nm.[37]
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pH Titration, Metal Selectivity, and Dissociation Constant
Buffered solutions at pH 3, 4, 5, 6, and 7 were prepared by mixing different volumes of 0.1
M citric acid and 0.2 M Na2HPO4 in water (Table SI-1) and the pH was verified using a
Mettler Toledo FE20 pH meter. The fluorescence of 5 μM SpiroZin1 in these buffered
solutions was measured before and after addition of 10 equiv. of ZnCl2 and the intensities
were normalized with respect to 5 μM SpiroZin1 at pH 7 before addition of ZnCl2.
To determine the metal selectivity of SpiroZin1, PIPES-buffered solutions (pH 7) containing
5 μM SpiroZin1 were prepared. To each solution, 100 equiv. of NaCl, MgCl2, CaCl2, CdCl2,
NiCl2, CuCl2, MnCl2, or CoCl2 were added and the fluorescence intensity measured. Cu+
was added as a solution of [Cu(CH3CN)4]PF6 in CH3CN to 5 μM SpiroZin1 in CH3CN
under nitrogen. To the same solutions, 100 equiv. of ZnCl2 were added and the fluorescence
intensity recorded. In each case, the fluorescence intensity was normalized with respect to 5
μM SpiroZin1 in aqueous buffer.
To determine the apparent dissociation constant (Kd), solutions containing 1 mM 1,2-
diaminohydroxypropanetetraacetic acid (DHPTA) and ZnCl2 were prepared. The total
concentration of Zn2+ was varied from 0.1 mM to 0.9 mM, to give buffered free Zn2+
concentrations ranging from 1.3 × 10−12 M to 1.1 × 10−10 M.[38] 5 μM SpiroZin1 was added
to each of these solutions, which were then equilibrated in the dark for 24 h. The
fluorescence of these solutions was measured and normalized with respect to 5 μM
SpiroZin1 in the presence of 100 equiv. of ZnCl2. The normalized fluorescence responses
(R) were plotted against the concentration of free Zn2+ [Zn] and the resulting data was fit to
the equation R = B[Zn]/(Kd + [Zn]), where B = 1. Minimization of this equation gave the
values B = 1.03(1), Kd = 2.1(1) × 10−11 M, and R2 = 0.995.
Kinetic Experiments
Zinc-induced ring opening of SpiroZin1 was monitored by stopped-flow UV-visible
spectroscopy configured with a single-wavelength photomultiplier and a tungsten lamp.
Stopped-flow data were obtained using a Hi-Tech Scientific SF-61 DX2 stopped-flow
spectrophotometer. The optical change at 508 nm was recorded to assess formation of the
cyanine isomer.
Solutions containing 5 μM SpiroZin1 and 500 μM ZnCl2 were prepared in aqueous buffer
(50 mM PIPES, 100 mM KCl, pH 7). The reactions were maintained at 25 °C with a
circulating water bath. Data points were collected on a logarithmic time scale (0.001–10s).
A dead time determination indicates that the first usable data points occur between 1 and 2
ms and the raw data was truncated accordingly. The data used for analysis are averages of
six independent measurements and were fit to a double exponential function: A = A0 +
B1exp[k1t] + B2exp[k2t], where A is the measured absorbance, A0 the initial absorbance, k1
and k2 the rate constants of the two steps, t is time, and B1 and B2 are constants.
Minimization of this equation gave the values k1 = 178(3) s−1, k2 = 0.59(1) s−1, R2 = 0.9997.
The ring-closing process was monitored by fluorescence spectroscopy. A solution
containing 5 μM SpiroZin1 and 5 μM ZnCl2 was prepared and allowed to equilibrate in the
dark for 1 h. The fluorescence of this solution was measured and 100 equiv. of EDTA were
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added. The fluorescence intensity was measured every 30 s. Fluorescence emission spectra
at each time point were integrated from 550 to 800 nm and plotted against time. The data
were fit to a single exponential function: F = F0 + B1exp[k1t], where F is the integrated
fluorescence, F0 the initial integrated fluorescence, k1 the rate constant, t is time, and B1 a
constant. Minimization of this equation gave the values k1 = 0.001351(1) s−1, R2 = 0.99992
DFT Calculations
All calculations were carried out using ORCA 2.9.1[39] employing the BP86 functional, the
TZVP basis set for C, N, O, and H, and the LANL2DZ basis set for Zn. The resolution of
the identity (RI) approximation, with the appropriate auxiliary basis sets, was used in all
calculations. Geometry optimizations were performed in solution by applying the implicit
conductor-like screening model (COSMO) for water. The nature of the stationary points was
characterized by harmonic vibrational analysis. All minima showed zero imaginary
frequencies, whereas all transition states gave only one imaginary frequency along the
reaction coordinate. Cartesian coordinates of all structures are provided in the SI.
Cell Culture and Staining Procedures
HeLa cells were cultured in Dulbecco’s modified Eagle medium (DMEM; Cellgro,
MediaTec, Inc.), supplemented with 10% fetal bovine serum (FBS; HyClone), 1%
penicillin-streptomycin, 1% sodium pyruvate, and 1% L-glutamine. The cells were grown to
90% confluence at 37 °C with 5% CO2 before being passed and plated onto poly-D-lysine
coated plates 24 h before imaging. Cells used were at passage number 7. A confluence level
of 50% was reached at imaging. The growth medium was replaced with dye-free DMEM
containing 5 μM SpiroZin1 and 2 μM Hoechst 33528 nuclear stain, and the cells were
incubated for 30 min. Cells were rinsed with PBS buffer (2 × 2 mL) before addition of fresh
dye-free DMEM (2 mL) and mounted on the microscope.
Fluorescence Microscopy
Imaging experiments were performed using a Zeiss Axiovert 200M inverted epifluorescence
microscope equipped with an EM-CCD digital camera (Hamamatsu) and a MS200 XY
Piezo Z stage (Applied Scientific Instruments). The light source was an X-Cite 120 metal-
halide lamp (EXFO) and the fluorescence images were obtained using an oil-immersion
objective at 63× magnification. The fluorescence filters sets used are defined as blue:
excitation G 365 nm, beamsplitter FT 395 nm, emission BP 445/50 nm; red: BP 550/25 nm,
beamsplitter FT 570 nm, emission BP 605/70 nm. The microscope was operated using
Volocity software (Perkin-Elmer).
The exposure time for acquisition of fluorescence images were kept constant for each series
of images at each channel. To measure analyte-induced fluorescence changes, the cells were
treated with dye-free DMEM containing 20 μM ZnCl2 and 50 μM pyrithione for 10 min. To
reverse the effect of zinc, the cells were exposed to dye-free DMEM containing 50 μM
TPEN for 15 min. All these experiments were carried out on the stage of the microscope.
Quantification of fluorescence intensity was performed using ImageJ (version 1.45, NIH).
The whole cell was selected as the region of interest. The integrated fluorescence from the
background region was subtracted from the cell body region.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Electronic absorption (solid lines) and fluorescence (dashed lines) spectra of SpiroZin1
before (grey lines) and after (black lines) addition of 10 equiv. of ZnCl2. All measurements
were performed using 5 μM SpiroZin1 in aqueous buffer (50 mM PIPES, 100 mM KCl, pH
7).
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Figure 2.
Integrated fluorescence intensity of 5 μM SpiroZin1 at different pH values before (white
bars) and after (grey bars) addition of 10 equiv. of ZnCl2. The intensities were normalized
with respect to 5 μM SpiroZin1 at pH 7 before addition of zinc.
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Figure 3.
Left: Increase in absorbance at 508 nm of 5 μM SpiroZin1 in aqueous buffer (50 mM PIPES,
100 mM KCl, pH 7) after addition of 100 equiv. of ZnCl2. Right: Decrease in integrated
fluorescence (550–800 nm, λex = 508 nm) of 5 μM of zinc-bound SpiroZin1 in aqueous
buffer (50 mM PIPES, 100 mM KCl, pH 7) after addition of 100 equiv. of EDTA.
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Figure 4.
Intrinsic reaction coordinate analysis of the zinc-induced, ring-opening reaction of
SpiroZin1. A) Ring-closed starting structure; B) Ring-opening transition state; C) Open, cis
cyanine intermediate; D) cis/trans isomerization transition state; E) Open, trans cyanine
product.
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Figure 5.
Microscopy images of live HeLa cells incubated with 5 μM SpiroZin1. A) differential
interference contrast (DIC) image; B) red channel image before addition of zinc pyrithione;
C) red channel image after incubation with 20 μM zinc pyrithione; D) red channel image
after incubating for 30 min with 50 μM TPEN. Scale bar = 25 μm. A color version of this
figure can be found in the Supporting Information.
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Scheme 1.
A) One-pot synthesis of SpiroZin1. Reactants and conditions: a) K2CO3, EtOH, reflux, 2 h,
40%. B) Reversible reaction of SpiroZin1 with Zn2+.
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